Primary angioplasty for acute myocardial infarction in octogenarians.

[1]  N. Powe,et al.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.

[2]  A. Timmis,et al.  How should age affect management of acute myocardial infarction? A prospective cohort study , 1999, The Lancet.

[3]  R. Califf,et al.  Effect of age on outcome with primary angioplasty versus thrombolysis. , 1999, Journal of the American College of Cardiology.

[4]  J. Gurwitz,et al.  Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). , 1998, The American journal of cardiology.

[5]  J. López-Sendón,et al.  Combined effect of age and right ventricular involvement on acute inferior myocardial infarction prognosis. , 1998, Circulation.

[6]  J. Gurwitz,et al.  Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction , 1998, Annals of Internal Medicine.

[7]  C. Di Mario,et al.  Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up. , 1998, Journal of the American College of Cardiology.

[8]  Yuan Zhang,et al.  Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.

[9]  K. Lee,et al.  Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.

[10]  P. Steg,et al.  Eligibility for reperfusion therapy and outcome in elderly patients with acute myocardial infarction. , 1994, European heart journal.

[11]  A. Maseri,et al.  Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .

[12]  B. McNeil,et al.  Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. , 1992, JAMA.

[13]  P. Kudenchuk,et al.  Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. , 1991, Journal of the American College of Cardiology.

[14]  E. Gilpin,et al.  Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. , 1990, Journal of the American College of Cardiology.

[15]  B. Rutherford,et al.  Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. , 1990, The American journal of cardiology.

[16]  R. W. Brower,et al.  Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarction. , 1988, Journal of the American College of Cardiology.

[17]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.

[18]  Logg Mh,et al.  Para-aminosalicylic acid in tuberculosis; early results of clinical trials. , 1947 .

[19]  B. Rutherford,et al.  Results of direct percutaneous transluminal coronary angioplasty in octogenarians. , 1996, The American journal of cardiology.

[20]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[21]  P. Shah,et al.  Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase. , 1987, The American journal of cardiology.